Back to Search
GERALD SIMON, M.D.
M.D.
Specialist
NPI: 1215014345Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
Research & Publications (20)
Amino acid precursors for the detection of transketolase activity in Escherichia coli auxotrophs.
PMID 19535247·Bioorg Med Chem Lett·2009
8-other
Comparative assessment of large-scale proteomic studies of apoptotic proteolysis.
PMID 19415908·ACS Chem Biol·2009
4-observational
Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions.
PMID 19266288·Curr Treat Options Oncol·2008
6-review
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
PMID 18300255·Cancer·2008
3-trial
Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer.
PMID 18241000·Future Oncol·2008
6-review
Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain.
PMID 18227059·J Biol Chem·2008
7-preclinical
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
PMID 17873178·Chest·2007
6-review
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
PMID 17602079·J Clin Oncol·2007
3-trial
Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality.
PMID 17600754·Int J Biochem Cell Biol·2007
6-review
N170 ERPs could represent a logographic processing strategy in visual word recognition.
PMID 17451598·Behav Brain Funct·2007
8-other
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.
PMID 16928835·Mol Cancer Ther·2006
3-trial
Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study.
PMID 16899614·Clin Cancer Res·2006
3-trial
Orthographic transparency and grapheme-phoneme conversion: An ERP study in Arabic and French readers.
PMID 16822485·Brain Res·2006
4-observational
Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
PMID 16818490·J Biol Chem·2006
7-preclinical
Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe.
PMID 16770602·Eur J Nucl Med Mol Imaging·2006
7-preclinical
MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
PMID 16557494·J Magn Reson Imaging·2006
4-observational
[MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
PMID 16435251·Rofo·2006
7-preclinical
Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.
PMID 16355039·Invest Radiol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3301 C ST, SUITE 200E
SACRAMENTO, CA 95816 - Phone
- (916) 447-6267
Quick Facts
- NPI
- 1215014345
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile